Combination of curcumin and green tea catechins prevents dimethylhydrazine-induced colon carcinogenesis

Food and Chemical Toxicology

Volumn 48, Issue 1, 2010, Pages 390-395

  Xu, Gang ^a   Ren, Guijie ^b   Xu, Xia ^b   Yuan, Huiqing ^b   Wang, Zhenzheng ^a   Kang, Ludong ^b   Yu, Wenguang ^b   Tian, Keli ^b  

^a 456 Hospital of Chinese PLA   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

ACF; Catechins; Colon cancer; Curcumin; DMH; Rat

Indexed keywords

CATECHIN; CURCUMIN; DIMETHYLHYDRAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DRUG POTENTIATION; MALE; NONHUMAN; RAT; TEA; TUMOR VOLUME;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CARCINOGENS; CATECHIN; COLON; COLONIC NEOPLASMS; COLORING AGENTS; CURCUMIN; DIMETHYLHYDRAZINES; DNA FRAGMENTATION; DRUG SYNERGISM; IN SITU NICK-END LABELING; INDICATORS AND REAGENTS; MALE; RATS; RATS, WISTAR; RECTUM; TEA;

RATTUS;

EID: 72149121289     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.10.027     Document Type: Article

References (33)

1. Aggarwal B.B., Kumar A., and Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23 (2003) 363-398
2. Aggarwal, B.B., Surh, Y.H., Shishodia, S., 2007. The molecular targets and therapeutics of curcumin in health and disease, vol. 995. Advances in Experimental Medicine and Biology. Springer Publication.
3. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., and Aggarwal B.B. Curcumin and cancer: an ''old-age" disease with an ''age-old" solution. Cancer Lett. 267 (2008) 133-164
4. Angelo L.S., and Kurzrock R. Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia. Clin. Cancer Res. 15 (2009) 1123-1125
5. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37 (1987) 147-151
6. Carter O., Dashwood R.H., Wang R., Dashwood W.M., Orner G.A., Fischer K.A., Löhr C.V., Pereira C.B., Bailey G.S., and Williams D.E. Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts. Nutr. Cancer 58 (2007) 60-65
7. Furukawa F., Nishikawa A., Kitahori Y., Tanakamaru Z., and Hirose M. Spontaneous development of aberrant crypt foci in F344 rats. J. Exp. Clin. Cancer Res. 21 2 (2002) 197-201
8. Ghosh A.K., Kay N.E., Secreto C.R., and Shanafelt T.D. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Clin. Cancer Res. 15 (2009) 1250-1258
9. Goel A., Kunnumakkara A.B., and Aggarwal B.B. Curcumin as curecumin: from kitchen to clinic. Biochem. Pharmacol. 75 (2008) 787-809
10. Jia X.D., and Han C. Chemoprevention of tea on colorectal cancer induced by dimethylhydrazine in Wistar rats. World J. Gastroenterol. 6 (2000) 699-703
11. Johnson J.J., and Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett. 255 (2007) 170-181
12. Katyama M., Yoshimi N., Yamada Y., Sakata K., Kuno T., Yoshida K., Qiao Z., Vihn P.Q., Iwasaki T., Kobayashi H., and Mori H. Preventive effect of fermented brown rice and rice bran against colon carcinogenesis in male F344 rats. Oncol. Rep. 9 4 (2002) 817-822
13. Kawamori T., Lubet R., Steele V.E., Kelloff G.J., Kaskey R.B., Rao C.V., and Reddy B.S. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 59 (1999) 597-601
14. Kelloff G.J., Crowell J.A., Steele V.E., Lubet R.A., Malone W.A., Boone C.W., Kopelovich L., Hawk E.T., Lieberman R., Lawrence J.A., Ali I., Viner J.L., and Sigman C.C. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J. Nutr. 130 (2000) 467S-471S
15. Khafif A., Schantz S.P., Chou T.-C., Edelstein D., and Sacks P.G. Quantitation of chemopreventive synergism between (2)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis 19 (1998) 419-424
16. Khan N., and Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett. 269 (2008) 269-280
17. Kunnumakkara A.B., Guha S., Krishnan S., Diagaradjane P., Gelovani J., and Aggarwal B.B. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 67 (2007) 3853-3861
18. Kunnumakkara A.B., Anand P., and Aggarwal B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269 (2008) 199-225
19. Li N., Chen X.X., Liao J., Yang G.Y., Wang S., Josephson Y., Han C., Chen J.S., Huang M.T., and Yang C.S. Inhibition of 7,12-dimethylbenz[α]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23 (2002) 1307-1313
20. Luebeck E.G., and Moolgavkar S.H. Multistage carcinogenesis and the incidence of colorectal cancer. PNAS 99 (2002) 15095-15100
21. Ohishi T., Kishimoto Y., Miura N., Shiota G., Kohri T., Hara Y., Hasegawa J., and Isemura M. Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane. Cancer Lett. 177 (2002) 49-56
22. Pisani P., Bray F., and Parkin D.M. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int. J. Cancer 97 (2002) 72-81
23. Sartippour M.R., Pietras R., Marquez-Garban D.C., Chen H.-W., Heber D., Henning S.M., Sartippour G., Zhange L., Lu M., Weinberg O., Rao J.Y., and Brooks M.N. The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 27 (2006) 2424-2433
24. Shpitz B., Giladi N., Sagiv E., Lev-Ari S., Liberman E., Kazanov D., and Arber N. Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model. Digestion 74 (2006) 140-144
25. Somers-Edgar T.J., Scandlyn M.J., Stuart E.C., Le Nedelec M.J., Valentine S.P., and Rosengren R.J. The combination of epigallocatechin gallate and curcumin suppresses ERa-breast cancer cell growth in vitro and in vivo. Int. J. Cancer 122 (2008) 1966-1971
26. Stuart E.C., Larsen L., and Rosengren R.J. Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231cells. Int. J. Oncol. 30 (2007) 1407-1412
27. Tanaka T., Kohno H., Shimada R., Kagami S., Yamaguchi F., Kataoka S., Ariga T., Murakami A., Koshimizu K., and Ohigashi H. Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. Carcinogenesis 21 (2000) 1183-1189
28. Volate S.R., Davenport D.M., Muga S.J., and Wargovich M.J. Modulation of aberrant crypt foci and apoptosis by dietaryherbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26 (2005) 1450-1456
29. Wijnands M.V., Van Erk M.J., Doornbos R.P., Krul C.A., and Woutersen R.A. Do aberrant crypt foci have predictive value for the occurrence of colorectal tumours? Potential of gene expression profiling in tumours. Food Chem. Toxicol. 42 (2004) 1629-1639
30. World Health Organization, Cancer, Fact sheet N°297.
31. Xiao H., Hao X., Simi B., Ju J., Jiang H., Reddy B.S., and Yang C.S. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis 29 (2008) 113-119
32. Yamane T., Hagiwara N., Tateishi M., Akachi S., Kim M., Okuzumi J., Kitao Y., Inagake M., Kuwata K., and Takahashi T. Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Jpn. J. Cancer Res. 82 (1991) 1336-1339
33. Yuan J.H., Li Y.Q., and Yang X.Y. Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4, 5-f]quinoline in mice. Mol. Med. 14 (2008) 590-598